home email sign-up search
HealthCast Calendar
Daily Reports Health Poll Search
Issue Spotlight
HealthCast
How to View
Search the HealthCast Archives
 

Site Search

 

Kaisernetwork.org is no longer publishing new content as of June 1, 2009.

The Kaiser Family Foundation continues to provide webcasts, podcasts and transcripts of Kaiser's events along with health policy briefings on the Hill conducted by the Alliance for Health Reform. You may access these webcasts, along with Kaiser's original videos and documentaries, on kff.org. All archived webcasts, podcasts and transcripts made available on kaisernetwork.org prior to June 1, 2009, continue to be available on-demand. You may search for webcasts here.


Global Medical Forum Summit: Is the U.S. Subsidizing the Global Pharmaceutical Market? A European Perspective"  12/5/2003
Global Medical Forum, Washington, D.C.

Compared to the United States, other major industrialized nations spend far less for the latest prescription drugs. Data suggests that it is not uncommon for consumers in Western Europe, for example, to spend 50% to 65% of what the American consumer spends for the same medications - often medications that are sold by U.S. companies and even manufactured in the U.S. At the same time, it is clear that governments in those countries have harmed the innovation process.

The summit addresses the following questions:

  • What can we learn from other leading Western systems about managing both the cost and use of pharmaceuticals?

  • Does the U.S. need to rethink its current laissez-faire policy toward the global pharmaceutical marketplace or not?

  • How do other Western systems control their prescription drug costs, both their price and their utilization. What are the true effects of these systems?

Welcome & Introduction Play Video ( video ) Read Transcript ( transcript )

Prof. Raphael H. Levey, M.D., chairman, Global Medical Forum Foundation
Mr. Robert Laszewski, chairman North America, Global Medical Forum

Case Studies Play Video ( video ) Read Transcript ( transcript )

Prof. Panos Kanavos, London School of Economics
"A Case Study from the European Market"
Interlocutor: Mr. James Roberts, president, Health Actuaries LLC

Mme. Annie Chicoye, founder and CEO, ACE
"How Pharmaceutical Pricing was Changed in France: A Lesson"
Mr. Tobias J. Levey, Global Medical Forum Foundation

Dr. Robert Geursen, fmr. SVP, Corporate Public Policy, Aventis Pharma.
"An Overview of Pharmaceutical Pricing in the European Community & the Effects of Reference Pricing"
Interlocutor: Dr. Paul Ginsburg, Center for Studying Health System Change

Case Solutions Play Video ( video ) Read Transcript ( transcript )

Dr. Heinz Redwood, consultant & advisor to Pharmaceutical Industry
"A Mid-Atlantic Approach to Rational Pharmaceutical Pricing"
Interlocutor: Ms. Jane Sarasohn-Kahn, THINK-Health & Affiliate - Institute for the Future

American Reaction Panel Play Video ( video ) Read Transcript ( transcript )

Ms. Kathleen Buto, vice president, Health Policy, Johnson & Johnson
Dr. Sharon Levine, The Permanente Medical Group, Kaiser Permanente
Interlocutor: Mr. Lawrence Leisure, managing partner - Health Services Industry, Accenture

Keynote Reaction Play Video ( video ) Read Transcript ( transcript )

Dr. Mark McClellan, commissioner, U.S. Food & Drug Administration
Interlocutor: Dr. John McLaughlin, The McLaughlin Group


Sign up for email alerts and stay informed about upcoming HealthCasts, and the latest health policy issues, news, and events.

Not sure if your computer is set up to view a HealthCast? For technical support on this or other issues:
Change Your Video Preferences
...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ...... ......


About Us     Help